Clinical Trial Update: Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1b study evaluating safety of AMG706 in combination with paclitaxel or docetaxel in locally recurrent and metastatic breast cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Locally Recurrent and Metastatic Breast Cancer

Drugs mentioned

• AMG706 (motesanib)
• DOCETAXEL (DOCETAXEL)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Amgen | Conditions: Locally Recurrent and Metastatic Breast Cancer | Phase 1 | Status: COMPLETED